Overview

A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)

Status:
Completed
Trial end date:
2015-10-05
Target enrollment:
Participant gender:
Summary
Evaluate the efficacy and safety of Lifitegrast in subjects with dry eye disease and a recent history of artificial tear use.
Phase:
Phase 3
Details
Lead Sponsor:
Shire
Treatments:
Lifitegrast
Ophthalmic Solutions